PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.22
ESG score 90-95% of AXSM's 59.55. Bill Ackman would demand clear ESG improvement catalysts.
51.62
Environmental score 90-95% of AXSM's 55.69. Bill Ackman would demand clear environmental improvement catalysts.
56.90
Social score 80-90% of AXSM's 63.57. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
57.14
Similar governance score to AXSM's 59.38. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.